Changes in lipid peroxidation activity in rats with congenital hypertension during candensartan treatment

Chopiak, V. V.; Kovpak, A. V.; Pastryk, T. V.; Mishchenko, I. V.

dc.contributor.author	Chopiak, V. V.	en
dc.contributor.author	Kovpak, A. V.	en
dc.contributor.author	Pastryk, T. V.	en
dc.contributor.author	Mishchenko, I. V.	en
dc.date.accessioned	2024-06-04T12:44:53Z
dc.date.available	2024-06-04T12:44:53Z
dc.date.issued	2023
dc.identifier.citation	Changes in lipid peroxidation activity in rats with congenital hypertension during candensartan treatment / V. V. Chopiak, A. V. Kovpak, T. V. Pastryk, I. V. Mishchenko // Science and technology: problems, prospects and innovations: the 4th International scientific and practical conference, January 18–20, 2023. CPN Publishing Group, Osaka, Japan. 2023. P. 29–39.	en
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/15441
dc.description.abstract	The article is devoted to the study of the peculiarities of the state of free radical peroxidation of lipids in rats with congenital arterial hypertension in the treatment of candesartan. In the test, it has been established that candesartan in SHR series rats normalizes the content of peroxide products of free radical reactions in myocardial homogenates and promotes the resistance of cardiomyocyte membranes lipids to reoxidation.	en
dc.language.iso	en	en
dc.subject	candesartan	en
dc.subject	arterial hypertension	en
dc.subject	free radical lipid peroxidation oxidation	en
dc.subject	spontaneously hypertensive rats of the SHR line	en
dc.title	Changes in lipid peroxidation activity in rats with congenital hypertension during candensartan treatment	en
dc.type	Article	en